Sequoia Financial Advisors LLC Increases Position in Gilead Sciences, Inc. $GILD

Sequoia Financial Advisors LLC has increased its stake in Gilead Sciences, Inc. by 16.9% in the second quarter, bringing its total holdings to 58,662 shares valued at $7.4 million. This move is part of broader institutional interest, with hedge funds and institutional investors collectively owning 83.67% of Gilead's stock. Despite some insider selling, analysts generally maintain a "Moderate Buy" rating for GILD, with an average price target of $158.78.